Explore Latest News .

Find all the latest news on Paul Peter Tak, as well as a comprehensive list of his past interviews and features. Paul Peter’s work in immunology and the pharmaceutical industry has led him to be featured in both business and medicine specific publications.

During his time at GlaxoSmithKline, Paul Peter gave a number of interviews and briefs, including one with the Biochemical Society in 2017. In this insightful interview, Paul Peter outlined what the GSK Immunology Network was and its impact on this important area of research.

In December 2020, Paul Peter Tak spoke with Eleanor Malone, from Scrip, about the work Candel Therapeutics was undertaking in the field of cancer immunotherapy and the companies ambitious future. Paul Peter has also had more broad discussions around his career and what inspires him, such as his interview with Stephanie Sutton for The Medicine Maker, in 2020.   

Viral immunotherapy. Interview with Dr. Moira Gunn at BioTech Nation

BioTech Nation … with Dr. Moira Gunn | Engineering Viruses to Treat Solid Tumors… Dr. Paul Peter Tak, CEO of Candel Therapeutics

Podcast Dr. Paul Peter Tak: Developing novel viral immunotherapies to improve cancer outcomes

How we stumbled on the role of the vagus nerve in chronic inflammation

Metagenics Institute Podcast: The Power and the Potential of the Vagus Nerve to Combat Inflammation with Prof Paul Peter Tak (

Just Two Years At the Helm, CEO Paul Peter Tak Transforms Candel and Cancer Treatment

Candel Therapeutics’ enLIGHTEN Discovery Platform has been launched with the announcement of a partnership with the University of Pennsylvania

Empowered patient podcast: Using oncolytic viral immunotherapy to kill solid tumors with Dr. Paul Peter Tak

Paul Peter Tak – Top podcast episodes (

Controlling Time: The Secret To Manufacturing

Controlling Time The Secret To Manufacturing (

Ignition of a new era of cancer treatments

Candel’s CEO looks to help ignite a new era of cancer treatments | PharmaVoice

EMPOWERED PATIENT PODCAST: Developing Immunotherapies Using Oncolytic Viruses to Change the Tumor Microenvironment

Pillars of success for building an innovative organisation.
Paul Peter Tak

© Paul Peter Tak.
All rights reserved.